Pulse Biosciences Inc (FRA:6L8)
€ 16.5 -0.2 (-1.2%) Market Cap: 1.13 Bil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 13.98 GF Score: 40/100

Q3 2020 Pulse Biosciences Inc Earnings Call Transcript

Nov 09, 2020 / 09:30PM GMT
Release Date Price: €9.91 (+1.00%)
Operator

Greetings and welcome to Pulse Biosciences' Third Quarter 2020 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Philip Taylor, Investor Relations. Thank you. You may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. Before we begin, I would like to inform you that comments and responses to your questions during today's call reflect management's views as of today, November 9, 2020, only and will include forward-looking statements and opinion statements. These include statements regarding our plans and expectations relating to regulatory clearance, including the process, time lines and expected outcomes; our commercial, operational, scientific, clinical and financial projections; products, including the uses, benefits and application of such products and our commercial and regulatory strategies, the impact of the COVID-19 pandemic and other future events. Actual results may differ materially from those expressed or

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot